NCT00440271 - SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Conditions

HIV Infections

Interventions

DRUG

tipranavir

DRUG

ritonavir

DRUG

Optimized Background Regimen (OBR)

Patients received between two and four active anti-retroviral medications based on resistance testing results, as background treatment, and remained on these for the duration of the trial.

Trial Locations (30)

Unknown

1182.98.033 Boehringer Ingelheim Investigational Site, Washington D.C.

1182.98.018 Boehringer Ingelheim Investigational Site, Clearwater

1182.98.014 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1182.98.041 Boehringer Ingelheim Investigational Site, Orlando

1182.98.004 Boehringer Ingelheim Investigational Site, Decatur

1182.98.002 Boehringer Ingelheim Investigational Site, Kansas City

1182.98.016 Boehringer Ingelheim Investigational Site, New York

1182.98.026 Boehringer Ingelheim Investigational Site, New York

1182.98.034 Boehringer Ingelheim Investigational Site, Stony Brook

1182.98.040 Boehringer Ingelheim Investigational Site, Huntersville

1182.98.006 Boehringer Ingelheim Investigational Site, Akron

1182.98.007 Boehringer Ingelheim Investigational Site, Cincinnati

1182.98.020 Boehringer Ingelheim Investigational Site, Oklahoma City

1182.98.029 Boehringer Ingelheim Investigational Site, Philadelphia

1182.98.023 Boehringer Ingelheim Investigational Site, Austin

1182.98.009 Boehringer Ingelheim Investigational Site, Houston

1182.98.5405 CENTRO de INFECTOLOGIA y ASISTENCIA (CIAS), Capital Federal ,Buenos Aires

1182.98.5403 Centro Hospital Higa - Dr Oscar Alende, Mar del Plata

1182.98.5402 Caici, Rosario

1182.98.55002 Hospital DIA, Sacomã - São Paulo

1182.98.55004 Unidade de Referência em doenças Infecciosas Preveníveis, Santo André

1182.98.55001 Universidade Federal de Sao Paulo, São Paulo

1182.98.55003 Centro de Referência e Treinamento - DST/AIDS, Vila Mariana - Sao Paulo

1182.98.1007 Boehringer Ingelheim Investigational Site, Quebec, Ste Foy

1182.98.4903 Boehringer Ingelheim Investigational Site, Bochum

1182.98.4908 Boehringer Ingelheim Investigational Site, Hamburg

1182.98.3907 Boehringer Ingelheim Investigational Site, Torino

1182.98.3402, Barcelona

1182.98.3405, Madrid

1182.98.3406, Madrid